Mitoxantrone, Etoposide, and Vinorelbine As Second-Line Therapy in Treating Patients With Metastatic Prostate Cancer That Did Not Respond to Hormone Therapy

NCT00627354 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

90

Enrollment

OTHER

Sponsor class

Conditions

Prostate Cancer

Interventions

DRUG: etoposide
DRUG: mitoxantrone hydrochloride
DRUG: prednisone
DRUG: vinorelbine tartrate

Sponsor

Groupe D'Etude des Tumeurs Uro-Genitales